Literature DB >> 31101765

miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.

Bruna Rodrigues Muys1,2,3,4,5, Josane F Sousa1,2,3,6, Jessica Rodrigues Plaça1,2,3, Luíza Ferreira de Araújo1,2,3,7, Aishe A Sarshad4, Dimitrios G Anastasakis4, Xiantao Wang4, Xiao Ling Li5, Greice Andreotti de Molfetta1,2,3, Anelisa Ramão1,2, Ashish Lal5, Daniel Onofre Vidal8, Markus Hafner9, Wilson A Silva10,2,3.   

Abstract

Dysregulation of miRNA expression is associated with multiple diseases, including cancers, in which small RNAs can have either oncogenic or tumor suppressive functions. Here we investigated the potential tumor suppressive function of miR-450a, one of the most significantly downregulated miRNAs in ovarian cancer. RNA-seq analysis of the ovarian cancer cell line A2780 revealed that overexpression of miR-450a suppressed multiple genes involved in the epithelial-to-mesenchymal transition (EMT). Overexpression of miR-450a reduced tumor migration and invasion and increased anoikis in A2780 and SKOV-3 cell lines and reduced tumor growth in an ovarian tumor xenographic model. Combined AGO-PAR-CLIP and RNA-seq analysis identified a panel of potential miR-450a targets, of which many, including TIMMDC1, MT-ND2, ACO2, and ATP5B, regulate energetic metabolism. Following glutamine withdrawal, miR-450a overexpression decreased mitochondrial membrane potential but increased glucose uptake and viability, characteristics of less invasive ovarian cancer cell lines. In summary, we propose that miR-450a acts as a tumor suppressor in ovarian cancer cells by modulating targets associated with glutaminolysis, which leads to decreased production of lipids, amino acids, and nucleic acids, as well as inhibition of signaling pathways associated with EMT. SIGNIFICANCE: miR-450a limits the metastatic potential of ovarian cancer cells by targeting a set of mitochondrial mRNAs to reduce glycolysis and glutaminolysis.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/13/3294/F1.large.jpg. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31101765      PMCID: PMC6606360          DOI: 10.1158/0008-5472.CAN-19-0490

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

3.  Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines.

Authors:  Wilhelm Gerhard Dirks; Silke Faehnrich; Isabelle Annick Janine Estella; Hans Guenter Drexler
Journal:  ALTEX       Date:  2005       Impact factor: 6.043

4.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

5.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.

Authors:  Lin Zhang; Stefano Volinia; Tomas Bonome; George Adrian Calin; Joel Greshock; Nuo Yang; Chang-Gong Liu; Antonis Giannakakis; Pangiotis Alexiou; Kosei Hasegawa; Cameron N Johnstone; Molly S Megraw; Sarah Adams; Heini Lassus; Jia Huang; Sippy Kaur; Shun Liang; Praveen Sethupathy; Arto Leminen; Victor A Simossis; Raphael Sandaltzopoulos; Yoshio Naomoto; Dionyssios Katsaros; Phyllis A Gimotty; Angela DeMichele; Qihong Huang; Ralf Bützow; Anil K Rustgi; Barbara L Weber; Michael J Birrer; Artemis G Hatzigeorgiou; Carlo M Croce; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

Review 6.  MicroRNAs in ovarian carcinomas.

Authors:  Neetu Dahiya; Patrice J Morin
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

7.  mt-Nd2a suppresses reactive oxygen species production by mitochondrial complexes I and III.

Authors:  Aaron M Gusdon; Tatyana V Votyakova; Clayton E Mathews
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

Review 8.  Autophagy and metastasis: another double-edged sword.

Authors:  Candia M Kenific; Andrew Thorburn; Jayanta Debnath
Journal:  Curr Opin Cell Biol       Date:  2009-11-27       Impact factor: 8.382

Review 9.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

10.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

View more
  20 in total

1.  Therapeutic potential of microRNAs in the regulation of cancer energy metabolism.

Authors:  Misa Yamamoto; Kenjiro Sawada; Tadashi Kimura
Journal:  Ann Transl Med       Date:  2019-12

2.  MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics.

Authors:  Siddhika Pareek; Aritro Nath; R Stephanie Huang
Journal:  Ann Transl Med       Date:  2019-12

3.  circCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate BRD4 signals.

Authors:  Xiang-Yang Zeng; Jing Yuan; Chen Wang; Da Zeng; Jia-Hui Yong; Xiao-Yan Jiang; Hua Lan; Song-Shu Xiao
Journal:  Mol Med       Date:  2020-07-08       Impact factor: 6.354

Review 4.  Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer.

Authors:  Yunuen Ortiz-Pedraza; J Omar Muñoz-Bello; Leslie Olmedo-Nieva; Adriana Contreras-Paredes; Imelda Martínez-Ramírez; Elizabeth Langley; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

Review 5.  MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities.

Authors:  Abraham Pedroza-Torres; Sandra L Romero-Córdoba; Montserrat Justo-Garrido; Iván Salido-Guadarrama; Rubén Rodríguez-Bautista; Sarita Montaño; Rodolfo Muñiz-Mendoza; Cristian Arriaga-Canon; Verónica Fragoso-Ontiveros; Rosa María Álvarez-Gómez; Greco Hernández; Luis A Herrera
Journal:  Front Oncol       Date:  2019-12-11       Impact factor: 6.244

6.  MicroRNAs and Their Targetomes in Tumor-Immune Communication.

Authors:  Sunglim Cho; Jesse W Tai; Li-Fan Lu
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 7.  The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.

Authors:  Han Yeoung Lee; Seung Wan Son; Sokviseth Moeng; Soo Young Choi; Jong Kook Park
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

Review 8.  Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer.

Authors:  Can Lu; Danting Zhou; Qiang Wang; Wenliang Liu; Fenglei Yu; Fang Wu; Chen Chen
Journal:  Oxid Med Cell Longev       Date:  2020-04-28       Impact factor: 6.543

9.  Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis.

Authors:  Li-Hsun Lin; Hsiu-Chuan Chou; Shing-Jyh Chang; En-Chi Liao; Yi-Ting Tsai; Yu-Shan Wei; Hsin-Yi Chen; Meng-Wei Lin; Yi-Shiuan Wang; Yu-An Chien; Xin-Ru Yu; Hong-Lin Chan
Journal:  J Cell Mol Med       Date:  2020-09-07       Impact factor: 5.310

Review 10.  The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.

Authors:  Vu Hong Loan Nguyen; Chenyang Yue; Kevin Y Du; Mohamed Salem; Jacob O'Brien; Chun Peng
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.